Gene · 10406
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of WFDC2 on the biological functions of cervical cancer cells and the regulation of the ERK/NF‑κB signaling pathway. | Oncol Rep | 2026 | 42396650 | PubTator, text mining | PubMed |
| Large-scale plasma proteomics improves prediction of heart failure among MASLD individuals: A prospective cohort study. | Am J Prev Cardiol | 2026 | 42395070 | PubTator, text mining | PubMed |
| piR-hsa-8111406 promotes proliferation and serves as a novel biomarker for early detection of ovarian cancer: a multi-center retrospective study. | Int J Gynecol Cancer | 2026 | 42391800 | PubTator, text mining | PubMed |
| Established and Emerging Less Invasive Biomarkers and Technologies for Lung Cancer Screening: Puerto Rican Context. | Onco (Basel) | 2026 | 42389670 | PubTator, text mining | PubMed |
| Enhancing the positive predictive value of early-stage ovarian cancer detection using a two-step machine learning framework. | J Transl Med | 2026 | 42387536 | PubTator, text mining | PubMed |
| Construction and validation of a preoperative malignancy risk prediction model for ovarian-adnexal masses based on clinical and ultrasonographic features. | Front Med (Lausanne) | 2026 | 42369149 | PubTator, text mining | PubMed |
| Diagnostic Potential of Selected Matrilysins and Stromelysins in the Diagnosis of Gynecological Malignancies Based on ROC Curve Analysis. | Int J Mol Sci | 2026 | 42353305 | PubTator, text mining | PubMed |
| Massive Ovarian Fibrothecoma Mimicking Advanced Ovarian Cancer in a High-Risk Patient: Diagnostic Challenges and Selective Use of Preoperative Biopsy. | Int J Womens Health | 2026 | 42344608 | PubTator, text mining | PubMed |
| A Nomogram for Preoperative Prediction of Ovarian Cancer Risk: A Single-Center Study from Vietnam. | Clin Ter | 2026 | 42340783 | PubTator, text mining | PubMed |
| Tumor markers in rheumatoid arthritis -associated interstitial lung disease: a systematic review and meta-analysis. | BMC Rheumatol | 2026 | 42337778 | PubTator, text mining | PubMed |
| A case of omental endometriosis complicated by hemorrhagic ascites leading to pelvic encapsulated effusion. | BMC Womens Health | 2026 | 42337492 | PubTator, text mining | PubMed |
| Endobody: Genetically Encodable Nanobody-CPP Chimeras for Degradation of Membrane and Extracellular Proteins. | Adv Sci (Weinh) | 2026 | 42335400 | PubTator, text mining | PubMed |
| A multimodal MRI radiomics model for distinguishing borderline from malignant ovarian epithelial tumors. | Clin Transl Oncol | 2026 | 42310186 | PubTator, text mining | PubMed |
| Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease. | Clin Lab | 2026 | 42295288 | PubTator, text mining | PubMed |
| Evaluation of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in non-small cell lung cancer: a prospective cohort study. | BMC Cancer | 2026 | 42271303 | PubTator, text mining | PubMed |
| Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules. | Ann Surg | 2026 | 42265763 | PubTator, text mining | PubMed |
| Serum Human epididymal protein 4 as a predictor of adverse events in acute ischemic stroke patients receiving antiplatelet therapy. | BMC Cardiovasc Disord | 2026 | 42265618 | PubTator, text mining | PubMed |
| Applications of artificial intelligence and machine learning models in the prognosis and diagnosis of ovarian cancer. | Front Oncol | 2026 | 42255239 | PubTator, text mining | PubMed |
| Gasdermin proteins as pyroptosis-based biomarkers in ovarian cancer: Diagnostic and prognostic utility. | Clin Chim Acta | 2026 | 42251925 | PubTator, text mining | PubMed |
| Prognostic value of CA125, HE4, ROMA, and CPH-I in advanced epithelial ovarian cancer. | BMC Cancer | 2026 | 42243732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10406/papers?page=3